Blog
RSS FeedPosted by Michael Wonder on 03 Jul 2023
IRA extends insulin cost caps to Medicare Part B and Medicare Advantage Starting 1 July
30 June 2023 - Starting 1 July, people with Medicare Part B and Medicare Advantage coverage who get their insulin through ...
Posted by Michael Wonder on 01 Jul 2023
CMS releases revised guidance for historic Medicare drug price negotiation program
30 June 2023 - For the first time in history, Medicare has the ability to directly negotiate the prices of covered ...
Posted by Michael Wonder on 24 Jun 2023
Medicare offers details on reimbursement for new Alzheimer's drugs
22 June 2023 - The US Medicare health plan on Thursday offered details of plans to collect patient data as ...
Posted by Michael Wonder on 22 Jun 2023
PhRMA sues Biden administration over Medicare drug price negotiations
21 June 2023 - The pharmaceutical industry’s largest lobbying group on Wednesday filed a lawsuit challenging provisions in the Biden ...
Posted by Michael Wonder on 21 Jun 2023
Pembrolizumab with lenvatinib for previously treated advanced or recurrent endometrial cancer
21 June 2023 - NICE has published final evidence-based recommendations on the use of pembrolizumab (Keytruda) in combination with lenvatinib ...
Posted by Michael Wonder on 21 Jun 2023
Teikoku Pharma granted FDA fast track designation for TPU-006, a novel 4 day dexmedetomidine transdermal system for post operative pain management
21 June 2023 - Teikoku Pharma today announced that the US FDA granted fast track designation for TPU-006 in managing post-operative ...
Posted by Michael Wonder on 21 Jun 2023
Dapagliflozin propanediol monohydrate for the treatment of adults with chronic heart failure with preserved or mildly reduced ejection fraction
21 June 2023 - NICE has published final evidence-based recommendations on the use of dapagliflozin propanediol monohydrate for the treatment ...
Posted by Michael Wonder on 02 Jun 2023
Here's how law makers can slash Medicare spending without cutting benefits
30 May 2023 - Politicians don't agree on much these days, but one thing seems to bring even Democrats and ...
Posted by Michael Wonder on 01 Jun 2023
CMS announces plan to ensure availability of new Alzheimer’s drugs
1 June 2023 - Agency outlines how people with Medicare can get these drugs if FDA grants traditional approval ...
Posted by Michael Wonder on 23 May 2023
US FDA approves the Cyltezo Pen, a new auto-injector option, ahead of 1 July commercial launch
22 May 2023 - Cyltezo (adalimumab-adbm) will be commercially available in the US beginning on 1 July 2023. ...
Posted by Michael Wonder on 15 May 2023
Medicare, FDA urged to press ahead with new Alzheimer’s drug Leqembi
12 May 2023 - Patients, law makers and Alzheimer’s advocates are pushing for Medicare to fully cover a new drug ...
Posted by Michael Wonder on 15 May 2023
Alzheimer’s treatment Leqembi could cost Medicare up to $5 billion per year, study estimates
12 May 2023 - The study authors said the estimated costs to the program for seniors are conservative and spending ...
Posted by Michael Wonder on 11 May 2023
Federal budget 2023: doctors praise $1.5 billion cash injection
10 May 2023 - The long-term trend of inadequate indexation of medical rebates is set to end after the federal ...
Posted by Michael Wonder on 02 May 2023
Medicare’s 'Coverage With Evidence Development': a barrier to patient access and innovation
1 May 2023 - During the George W. Bush administration, the Centers for Medicare and Medicaid Services introduced a program known ...
Posted by Michael Wonder on 01 May 2023
Rebuilding Medicare for the 21st century
28 April 2023 - The Australian Government is laying the foundations for significant reforms to Medicare, with a comprehensive package of ...